<DOC>
	<DOCNO>NCT00355953</DOCNO>
	<brief_summary>The present research program propose deepen pharmacological effect genistein therapy order individualize alternative treatment conventional hormonal replacement therapy useful reduce cardiovascular morbidity mortality osteoporotic consequence postmenopausal woman .</brief_summary>
	<brief_title>Vascular Skeletal Protective Effects Genistein Postmenopausal Women</brief_title>
	<detailed_description>Genistein phytoestrogen isoflavone family show beneficial effect endothelial function bone metabolism . On basis far obtain result , aim research investigate two year period effect genistein cardiovascular risk factor , endothelial function oxidative stress marker , bone metabolism finally clarify pathophysiology mechanism ( dosage cytokine endothelial marker ) molecule could interfere atherosclerosis bone mass loss progression . Particularly , extreme synthesis follow parameter study treatment : 1. inflammation marker fibrinogen 2. lipid profile - total cholesterol , LDL cholesterol , HDL cholesterol , triglyceride , lipoprotein ( ) - 3. endothelial function marker VCAM-1 ICAM-1 4. oxidative stress evaluation F ( 2 ) -isoprostane 5. cytokine IL-6 , OPG , RANK RANKL 6. bone mineral density , DEXA , lumbar spine femoral neck 7 . Bone turnover marker B-ALP , PYR , D-PYR 8 . PAP-test , transvaginal uterine ecography mammography .</detailed_description>
	<mesh_term>Bone Diseases , Metabolic</mesh_term>
	<mesh_term>Genistein</mesh_term>
	<criteria>At least one year menopause No use hormone replacement therapy Bone mineral density Tscore femoral neck minor one S.D . Concomitant disease Smoke habit</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Post-Menopausal Women</keyword>
	<keyword>Osteoporosis</keyword>
	<keyword>Phytoestrogen</keyword>
	<keyword>Genistein</keyword>
</DOC>